Please Wait
Applying Filters...
menu
    • menu

    Digital Content for NCGC00024907-01

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    NCGC00024907-01

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,647Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Soleno Therapeutics Announces DCCR Regulatory Update
    Soleno Therapeutics Announces DCCR Regulatory Update

    08 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/10/08/2959708/0/en/Soleno-Therapeutics-Announces-Regulatory-Update-on-DCCR-diazoxide-choline-Extended-Release-Tablets-to-Treat-Prader-Willi-Syndrome.html

    GLOBENEWSWIRE
    08 Oct 2024
    Share Share
    Soleno Therapeutics To Present At Cantor Healthcare Conference
    Soleno Therapeutics To Present At Cantor Healthcare Conference

    16 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/16/2947017/0/en/Soleno-Therapeutics-to-Present-at-2024-Cantor-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    16 Sep 2024
    Share Share
    Soleno Therapeutics Announces Inducement Grants Under Nasdaq Rule
    Soleno Therapeutics Announces Inducement Grants Under Nasdaq Rule

    19 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/19/2932445/0/en/Soleno-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    19 Aug 2024
    Share Share
    Soleno Submits New Drug Application To FDA For DCCR To Treat Willi Syndrome
    Soleno Submits New Drug Application To FDA For DCCR To Treat Willi Syndrome

    28 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/28/2905801/0/en/Soleno-Therapeutics-Announces-Submission-of-New-Drug-Application-to-the-U-S-FDA-for-DCCR-Diazoxide-Choline-Extended-Release-Tablets-for-the-Treatment-of-Prader-Willi-Syndrome.html

    GLOBENEWSWIRE
    28 Jun 2024
    Share Share
    Soleno Announces DCCR Prader-Willi Data At ENDO 2024
    Soleno Announces DCCR Prader-Willi Data At ENDO 2024

    22 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/22/2886835/0/en/Soleno-Therapeutics-Announces-Oral-Presentation-featuring-DCCR-Diazoxide-Choline-Extended-Release-Tablets-in-Prader-Willi-Syndrome-at-ENDO-2024.html

    GLOBENEWSWIRE
    22 May 2024
    Share Share
    Soleno's DCCR Gets FDA Breakthrough Designation in PWS
    Soleno's DCCR Gets FDA Breakthrough Designation in PWS

    29 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/29/2871167/0/en/Soleno-Therapeutics-Receives-Breakthrough-Therapy-Designation-from-U-S-FDA-for-DCCR-Diazoxide-Choline-Extended-Release-Tablets-in-Prader-Willi-Syndrome-PWS.html

    GLOBENEWSWIRE
    29 Apr 2024
    Share Share